DHFR and rheumatoid arthritis: Methotrexate (4-amino-10-methyl folic acid, MTX) is a competitive irreversible inhibitor of dihydrofolate reductase (DHFR) [9] that is effectively used in the treatment of cancer, rheumatoid arthritis, and other inflammatory diseases [10–12].